Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A 1000 cc Intragastric Balloon for Weight Reduction.

A Lavy1, J Lachter, O Zinder

  • 1Gastroenterology Unit Rambam Medical Center Haifa Israel.

Diagnostic and Therapeutic Endoscopy
|May 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surveillance for pancreatic cancer in high-risk individuals.

BJS open·2019
Same author

Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trial.

The American journal of gastroenterology·2015
Same author

Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.

Clinical and experimental immunology·2015
Same author

Opposite-side flavour tagging of <i>B</i> mesons at the LHCb experiment.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of <b></b> production in <b></b> collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same author

Measurement of <i>ψ</i>(2<i>S</i>) meson production in <i>pp</i> collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same journal

Endoscopic Ultrasound Elastography for Evaluation of Lymph Nodes: A Single Center Experience.

Diagnostic and therapeutic endoscopy·2018
Same journal

Unsuspected Small-Bowel Crohn's Disease in Elderly Patients Diagnosed by Video Capsule Endoscopy.

Diagnostic and therapeutic endoscopy·2018
Same journal

The Role of EUS-BD in the Management of Malignant Biliary Obstruction: The Indonesian Perspective.

Diagnostic and therapeutic endoscopy·2017
Same journal

Extended Cystogastrostomy with Hydrogen Peroxide Irrigation Facilitates Endoscopic Pancreatic Necrosectomy.

Diagnostic and therapeutic endoscopy·2017
Same journal

Comparison of the Diagnostic Yield of EUS Needles for Liver Biopsy: Ex Vivo Study.

Diagnostic and therapeutic endoscopy·2017
Same journal

Use of 4-Fr versus 6-Fr Nasobiliary Catheter for Biliary Drainage: A Prospective, Multicenter, Randomized, Controlled Study.

Diagnostic and therapeutic endoscopy·2017
See all related articles

A 1000 cc intragastric balloon did not significantly aid weight loss in morbidly obese patients over six months. Hormone level changes, specifically Bombesin, warrant further investigation for their role in weight management.

Area of Science:

  • Bariatric surgery and metabolic disorders
  • Gastroenterology
  • Endocrinology

Background:

  • Morbid obesity is a significant health concern requiring effective weight reduction strategies.
  • Intragastric balloons are a less invasive option for weight management compared to bariatric surgery.
  • Previous studies show variable success rates for intragastric balloons in promoting sustained weight loss.

Purpose of the Study:

  • To evaluate the efficacy of a 1000 cc intragastric balloon in facilitating weight reduction among morbidly obese individuals.
  • To assess the impact of the intragastric balloon on hormonal profiles related to appetite and metabolism.

Main Methods:

  • A cohort of 33 morbidly obese patients with prior unsuccessful weight loss attempts participated.
  • Endoscopic insertion of a 1000 cc intragastric balloon, retained for six months.

Related Experiment Videos

  • Patients received concurrent dietary therapy; hormone levels (Bombesin, Gastrin) were measured pre- and post-intervention.

    • Main Results:

    • A modest initial weight loss was followed by significant weight regain in most participants.
    • The mean weight loss after six months was only 8 kg (range 0-22 kg).
    • Bombesin levels significantly decreased post-therapy, while Gastrin levels showed no significant change.

    Conclusions:

    • A large-volume intragastric balloon for six months is not an effective long-term aid for weight reduction in morbidly obese patients.
    • The observed significant reduction in Bombesin levels suggests a potential hormonal response to the balloon, meriting further research.